JENNIFER JOHNSTON: Open Payments
NPI 1023687977 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 52 payments from 22 companies in 2025. Trend: 2023 $1,362 · 2024 $1,404 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Lilly USA, LLC | 8 | $136 |
| PFIZER INC. | 4 | $73 |
| Novo Nordisk Inc | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Axsome Therapeutics, Inc. | 3 | $44 |
| Exact Sciences Corporation | 2 | $32 |
| Corium, LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: MOUNJARO, QULIPTA, ZEPBOUND, VRAYLAR, Ozempic, Auvelity, NURTEC ODT, UBRELVY.
Industry payments across IN — which companies pay providers there.
